top of page

Wed, 01 May



Biotech Investing in Longevity: Aikora Health and the Foresight Institute in San Francisco

Join Aikora Health and the Foresight Institute for an evening of talks on biotech investment and longevity. This event will be taking place on the 1st of May in San Francisco. Registration is now closed.

Registration is now Closed
See other events
Biotech Investing in Longevity: Aikora Health and the Foresight Institute in San Francisco
Biotech Investing in Longevity: Aikora Health and the Foresight Institute in San Francisco

Time & Location

01 May 2019, 18:00 – 21:00

IndieBio, 479 Jessie St, San Francisco, CA 94103, USA

About The Event

*Registration is now closed*

Join Aikora Health and the Foresight Institute for a series of talks on biotech investment and longevity. We’ll be gathering a curated group of entrepreneurs, scientists, and investors to discuss exciting projects that seek to extend human healthspan, surveying a diversity of novel approaches, and discussing which ambitious goals are realistically within our reach.

This event will be taking place on 1st May in San Francisco, and will include snacks, drinks, debate and planning.

The speakers will include:

  • Mark Katakowski, President and CSO of Forever Labs
  • Sergio Ruiz, Managing Director of the Methuselah Fund
  • Reason, CEO of Repair Biotechnologies
  • Doug Ethell, CEO of Leucadia Therapeutics
  • Vittorio Sebastiano, Scientific Advisory Board Chairman of Turn Biotechnologies
  • Aubrey de Grey, CSO of SENS Research Foundation
  • Sonia Arrison, Author of 100 Plus
  • Sarah Constantin, Executive Director of The Longevity Research Institute
  • Gordon Lithgow, Professor at the Buck Institute for Research on Aging
  • Mike West, CEO of AgeX Therapeutics

Our gold sponsor for this event is Forever Labs.

Forever Labs cryopreserves your adult stem cells to create a reservoir of young stem cells for future use. The decline in the number and viability of stem cells contributes to the decline in health associated with aging. Stem cell replacement experiments in mice suggest that young-to-old transplantation of stem cells can extend healthy lifespan. Mark Katakowski co-founded Forever Labs with the goal to bring autologous stem cell replacement therapy to humans.

Our silver sponsors are The Methuselah Fund and Repair Biotechnologies.

The Methuselah Fund is designed to accelerate results in the longevity field, extending the healthy human lifespan. They measure their success not just by financial return-on-investments but also by what they call return-on-mission. Their DNA stems from The Methuselah Foundation, which has been working hard during the last 18 years to make 90 the new 50 by 2030. They leverage their founding position within this new industry to get unfair visibility into the science and teams that have the potential for disruptive scientific and financial returns.

Repair Biotechnologies is a longevity company with the mission to develop and bring to the clinic therapies that significantly improve human healthspan through targeting the causes of age-related diseases and aging itself. The company currently runs two preclinical development programs: the first for thymus regeneration and immune system restoration, and the second for reversal of atherosclerosis.

The Foresight Institute is a leading think tank and public interest organization focused on emerging world-shaping technologies. It was founded in 1986 on a vision of coming revolutions in technology that will bring extraordinary opportunities, as well as unprecedented challenges. Foresight's mission is to steer towards positive futures, futures of Existential Hope.

Share This Event

bottom of page